RegentAtlantic Capital’s Pediatrix Medical MD Stock Holding History

RegentAtlantic Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-994	Closed	-$65.7K	–	681
2014 Q4	$65.7K	Buy	+994	New	+$60.7K	0.01%	534

Other funds holding MD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

CPCM

Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RegentAtlantic Capital's MD Position: Q1 2015 in Review

RegentAtlantic Capital sold out of Pediatrix Medical (MD) in Q1 2015, closing a stake of 994 shares — an estimated $65.7K sold.

RegentAtlantic Capital first reported a position in MD in Q4 2014 and held it in 1 quarter. The position peaked at $65.7K in Q4 2014. 353 funds tracked by Wall St. Rank hold MD as of Q1 2015.

RegentAtlantic Capital reported no remaining Pediatrix Medical position as of Q1 2015 after selling out during the quarter.
RegentAtlantic Capital sold 994 Pediatrix Medical shares in Q1 2015, an estimated $65.7K.
RegentAtlantic Capital first reported a position in Pediatrix Medical in Q4 2014 and held it in 1 quarter.
RegentAtlantic Capital's Pediatrix Medical position peaked at $65.7K in Q4 2014.
353 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2015.

Based on RegentAtlantic Capital's 13F filing for Q1 2015, filed 27 Apr 2015.